Incorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary Embolism
Recovery After Acute Pulmonary Embolism
University of Rochester
100 participants
Feb 27, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of the ERAsE-PE study is to determine whether two different healthy living strategies (along with anticoagulation) might aid in recovery after a patient is hospitalized for pulmonary embolism. Specifically, Investigators will compare changes in Cardiac Effort (#heart beats used during the 6-minute walk test/walk distance) measured after an 8-week program.
Eligibility
Inclusion Criteria7
- English speaking (>18 years old). Daily messages will be sent in English.
- Acute PE with at least one of the following:
- any right ventricular enlargement or dysfunction on echocardiogram;
- CT Angiogram reporting any right ventricular enlargement; or
- elevated cardiac biomarker (NT-pro BNP or troponin above baseline). Criteria for enrollment will be included on source document.
- Rate controlled atrial arrythmias (resting heart rate <110 beats/m) are eligible for enrollment. This includes atrial fibrillations. This is standard of care management for atrial fibrillation.
- Subjects do need to take prescribed anticoagulation.
Exclusion Criteria9
- Pregnancy.
- Cardiac Effort >3.5 beats/m during 6MWT.
- Resting tachycardia >110 beats/m at hospital discharge.
- Chronic Thromboembolic Pulmonary Hypertension
- Systolic blood pressure >180 mmHg at hospital discharge.
- Inability to walk.
- Estimated prognosis <12 months at the time of discharge due to underlying co-morbidities (e.g., cancer).
- Advanced neurologic disease and would not be able to comply with the messages.
- Lack of access to email or text messaging 10. Inability or unwillingness to follow daily instructions.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive a text or email each day with instructions about a healthy intervention.
Participants will receive a text or email each day with instructions about a healthy intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06784492